REGISTERED NUMBER: 09700115 (England and Wales)

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2024

FOR

CARE PHARMA BRADFORD LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

M I Lakhi

M L Asghar

M Bashir

SECRETARY:

REGISTERED OFFICE:

Chesterfield House

Broad Lane

Bradford

West Yorkshire

BD4 8PW

REGISTERED NUMBER:

09700115 (England and Wales)

ACCOUNTANTS:

Southbrook Accountants Limited

14 Southbrook Terrace

Bradford

West Yorkshire

BD7 1AD

FIXED ASSETS

Tangible assets

4

7,842

10,077

CURRENT ASSETS

Stocks

92,387

91,302

Debtors

5

359,810

212,972

Cash at bank

327,135

322,459

779,332

626,733

CREDITORS

Amounts falling due within one year

6

609,813

509,945

NET CURRENT ASSETS

169,519

116,788

TOTAL ASSETS LESS CURRENT LIABILITIES

177,361

126,865

CAPITAL AND RESERVES

Called up share capital

3

3

Retained earnings

177,358

126,862

SHAREHOLDERS' FUNDS

177,361

126,865

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 April 2025 and were signed on its behalf by:

M I Lakhi - Director

M Bashir - Director

M L Asghar - Director

1.	STATUTORY INFORMATION

Care Pharma Bradford Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

15% on reducing balance

Computer equipment

-

33% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2023 - 16 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1 August 2023

and 31 July 2024

11,112

4,470

15,582

DEPRECIATION

At 1 August 2023

2,480

3,025

5,505

Charge for year

1,523

712

2,235

At 31 July 2024

4,003

3,737

7,740

NET BOOK VALUE

At 31 July 2024

7,109

733

7,842

At 31 July 2023

8,632

1,445

10,077

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

170,504

158,944

Other debtors

189,306

54,028

359,810

212,972

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade creditors

368,560

351,738

Taxation and social security

16,557

11,709

Other creditors

224,696

146,498

609,813

509,945

7.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is M I Lakhi.